Valion Bio (VBIO) Liabilities and Shareholders Equity (2021 - 2026)
Valion Bio's Liabilities and Shareholders Equity was $32.47 million in Q2 2026, up 620.3% from $4.51 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Liabilities and Shareholders Equity at Valion Bio came in at $31.61 million.
- Liabilities and Shareholders Equity shows a four-year compound annual growth rate of 20.4% (FY2021 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $2.81 million in FY2024 (-45.6%), $5.16 million in FY2023 (-12.2%), $5.88 million in FY2022 (-60.9%) and $15.04 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2021.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last six quarters, with growth averaging 102.7%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q2 2026 (growth of 620.3%); the worst was Q4 2022 (a decline of 60.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | 32.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.47 Mn |
| Dec 31, 2025 | 31.61 Mn |
| Sep 30, 2025 | 6.23 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 7.01 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 7.10 Mn |
| Dec 31, 2022 | 5.88 Mn |
| Sep 30, 2022 | 8.21 Mn |
| Jun 30, 2022 | 11.03 Mn |
| Mar 31, 2022 | 12.69 Mn |
| Dec 31, 2021 | 15.04 Mn |
API Access
Valion Bio Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();